Phytic Acid
CAS 83-86-3
Phytic Acid (CAS 83-86-3) is a Phase 3 pharmaceutical compound with 2 bioactivity targets and 11 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | EC50 | 8390 nM | 1 | - |
| - | Kd | 1360 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| PHYTIC ACID | 8302 | SU | MTHSPL |
| FYTIC ACID | 8302 | SU | MTHSPL |
| fytic acid | 8302 | SU | MTHSPL |
| phytic acid | 8302 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Phytic Acid used for in pharmaceutical contexts?
Phytic Acid (CAS 83-86-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Phytic Acid?
Phytic Acid has 11 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Accidental overdose, Alanine aminotransferase increased, Aspartate aminotransferase increased, Diarrhoea, Dyspepsia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Phytic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Phytic Acid with EU status "permitted".
What clinical phase is Phytic Acid in?
Phytic Acid is rendered with ChEMBL max phase 3.